Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Арка Байофарма Инк.filedCriticalАрка Байофарма Инк.
Priority claimed from PCT/US2019/034019external-prioritypatent/WO2019227056A2/en
Publication of EA202092869A1publicationCriticalpatent/EA202092869A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Способы и композиции по настоящему изобретению относятся к лечению фибрилляции предсердий буциндололом у пациентов, включая пациентов с сердечной недостаточностью, после определения того, что они являются гомозиготными по Arg389 в гене 1-адренергического рецептора.The methods and compositions of the present invention relate to the treatment of atrial fibrillation with bucindolol in patients, including patients with heart failure, after determining that they are homozygous for Arg389 in the 1-adrenergic receptor gene.
EA202092869A2019-04-262019-05-24
METHODS AND COMPOSITIONS INCLUDING BUCINDOLOL FOR ATRIAL FIBRILLATION TREATMENT
EA202092869A1
(en)